Studies have demonstrated that RUNX3 was significantly hypermethylated in HBV-related HCC [56], while during AFB1-induced hepatocytes’ malignant transformation, RUNX3 exhibited a dynamic DNA methylation shift, transitioning from initial hypomethylation to hypermethylation [40]. Here, RUNX3 is linked to hepatocellular carcinoma.